Hologic (HOLX) Rating Reiterated by Royal Bank of Canada

Hologic (HOLX) Rating Reiterated by Royal Bank of Canada


's stock had its "hold" rating restated by research analysts at Royal Bank of Canada in a research report issued on Friday. They presently have a $44.00 price objective on the medical equipment provider's stock.



from Biotech News